Rifat Serav Ilhan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Rifat Serav Ilhan has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Berker Duman
Department of Psychiatry, Ankara University School of Medicine, Ankara, Türkiye
3 shared publications- Bedriye Öncü
Ankara Üniversitesi
2 shared publications Burçin Çolak
Department of Psychiatry, Ankara University School of Medicine, Ankara, Türkiye
2 shared publications- Burçin Çolak
Department of Psychiatry, Faculty of Medicine, Ankara University, Ankara, Turkey
2 shared publications Emine Uslu
Department of Rheumatology, Ankara University School of Medicine, Ankara, Türkiye
2 shared publications- Ezgi Sıla Ahi Üstün
Mamak State Hospital
2 shared publications
Latest Publications
- Open Access
- 18 March 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Independent role of alexithymia on weight loss outcomes in obese women: a six month follow-up study
The relationship between difficulties in emotion regulation and obesity has received a great deal of attention. This study aimed to investigate whether alexithymia affects the success of weight loss in obese women, and whether this is mediated by depression. This prospective longitudinal study was conducted at an obesity centre, where female patients were enrolled in a six-month diet and education programme. At the beginning of the programme, the Toronto Alexithymia Scale (TAS-20) and the Beck Depression Inventory (BDI) were used to assess levels of alexithymia and depression, respectively. Body mass index (BMI) was also calculated. At the end of six months, BMI was calculated again. The mediating role of the depressive symptoms in the association between the alexithymia and the rate of change in BMI(cBMI) was examined using the Process v4.2 package by Andrew F. Hayes, with model 4 being employed. The bootstrap method was used to test the indirect effect. The study included 49 obese women. There was a statistically significant negative correlation between cBMI and TAS-20 score at baseline (ρ= -0.756; p < 0.001), whereas there was no statistically significant correlation between BDI score and cBMI (ρ = 0.037; p = 0.802). In the regression model, alexithymia was independently associated with cBMI (p < 0.001), while depressive symptoms were not independently associated with changes in BMI (p = 0.690). The indirect effect of the TAS-20 score on cBMI via depression was not statistically significant. Higher levels of alexithymia were associated with poorer weight loss outcomes in obese women, independent of depressive symptom severity. The online version contains supplementary material available at 10.1186/s12905-026-04399-x.
- 18 March 2026
- Published by Springer Nature in BMC Women's Health
- Vol. 26 (1)
Open AccessIndependent role of alexithymia on weight loss outcomes in obese women: a six month follow-up study
The relationship between difficulties in emotion regulation and obesity has received a great deal of attention. This study aimed to investigate whether alexithymia affects the success of weight loss in obese women, and whether this is mediated by depression. This prospective longitudinal study was conducted at an obesity centre, where female patients were enrolled in a six-month diet and education programme. At the beginning of the programme, the Toronto Alexithymia Scale (TAS-20) and the Beck Depression Inventory (BDI) were used to assess levels of alexithymia and depression, respectively. Body mass index (BMI) was also calculated. At the end of six months, BMI was calculated again. The mediating role of the depressive symptoms in the association between the alexithymia and the rate of change in BMI(cBMI) was examined using the Process v4.2 package by Andrew F. Hayes, with model 4 being employed. The bootstrap method was used to test the indirect effect. The study included 49 obese women. There was a statistically significant negative correlation between cBMI and TAS-20 score at baseline (ρ= -0.756; p < 0.001), whereas there was no statistically significant correlation between BDI score and cBMI (ρ = 0.037; p = 0.802). In the regression model, alexithymia was independently associated with cBMI (p < 0.001), while depressive symptoms were not independently associated with changes in BMI (p = 0.690). The indirect effect of the TAS-20 score on cBMI via depression was not statistically significant. Higher levels of alexithymia were associated with poorer weight loss outcomes in obese women, independent of depressive symptom severity. The online version contains supplementary material available at 10.1186/s12905-026-04399-x.
- Open Access
- 14 November 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1659408
Cognitive functions in euthymic bipolar I and II patients: a cross sectional study
Introduction: This study aimed to compare the neurocognitive profiles of euthymic patients with bipolar I (BD-I) and bipolar II (BD-II) disorder and healthy controls, while controlling for confounding clinical and pharmacological variables, to determine whether observed cognitive differences reflect true subtype distinctions or are secondary to illness burden. Methods: We assessed 78 clinically stable outpatients with BD-I or BD-II and 40 healthy controls using a comprehensive neuropsychological battery that included tests of verbal episodic memory, executive functioning, processing speed, attention, and working memory. All patients were in euthymia and receiving stable monotherapy. Analyses of covariance (ANCOVA) were conducted to compare group performance, adjusting for age, illness duration, number of depressive episodes, hospitalizations, and chlorpromazine-equivalent doses of antipsychotics and mood stabilizers. Results: Both BD subtypes demonstrated significant cognitive impairments relative to controls. BD-I patients showed broader and more severe deficits, especially in verbal episodic memory and executive flexibility. Importantly, only verbal memory impairments remained significant after full covariate adjustment, indicating a potential trait-like vulnerability in BD-I. Differences in executive function, processing speed, and attention between BD-I and BD-II were primarily explained by illness severity and medication exposure. Verbal episodic memory represents a robust and subtype-specific cognitive impairment in BD-I, whereas other cognitive differences between BD-I and BD-II are primarily attributable to modifiable clinical factors. Discussion: These findings underscore the importance of integrating cognitive evaluation into routine care and suggest that cognitive profiles may inform personalized interventions and diagnostic clarification in bipolar disorder.
- 14 November 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1659408
Open AccessCognitive functions in euthymic bipolar I and II patients: a cross sectional study
Introduction: This study aimed to compare the neurocognitive profiles of euthymic patients with bipolar I (BD-I) and bipolar II (BD-II) disorder and healthy controls, while controlling for confounding clinical and pharmacological variables, to determine whether observed cognitive differences reflect true subtype distinctions or are secondary to illness burden. Methods: We assessed 78 clinically stable outpatients with BD-I or BD-II and 40 healthy controls using a comprehensive neuropsychological battery that included tests of verbal episodic memory, executive functioning, processing speed, attention, and working memory. All patients were in euthymia and receiving stable monotherapy. Analyses of covariance (ANCOVA) were conducted to compare group performance, adjusting for age, illness duration, number of depressive episodes, hospitalizations, and chlorpromazine-equivalent doses of antipsychotics and mood stabilizers. Results: Both BD subtypes demonstrated significant cognitive impairments relative to controls. BD-I patients showed broader and more severe deficits, especially in verbal episodic memory and executive flexibility. Importantly, only verbal memory impairments remained significant after full covariate adjustment, indicating a potential trait-like vulnerability in BD-I. Differences in executive function, processing speed, and attention between BD-I and BD-II were primarily explained by illness severity and medication exposure. Verbal episodic memory represents a robust and subtype-specific cognitive impairment in BD-I, whereas other cognitive differences between BD-I and BD-II are primarily attributable to modifiable clinical factors. Discussion: These findings underscore the importance of integrating cognitive evaluation into routine care and suggest that cognitive profiles may inform personalized interventions and diagnostic clarification in bipolar disorder.
- Open Access
- 1 October 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-15
Clinical implications of autistic features in the psychosis spectrum: a cross-sectional study using path analysis
Despite the fact that there have been many studies on the connection between autism and psychosis, there are still many things that are unknown about the significance of this connection. Recent studies have highlighted the significant overlap between autistic traits and psychotic disorders, yet the clinical implications of these associations are not well understood. This study aims to address this knowledge gap by investigating the links between autistic features and various clinical, functional and behavioural outcomes in individuals with psychosis spectrum. The study included 125 patients who had at least one psychotic episode and who had used antipsychotic medication for most of the treatment period. The clinician conducted face-to-face interviews to evaluate all other clinical characteristics, while self-report scales were employed to evaluate autistic features and quality of life. Complex associations were understood using path analysis. Our study showed that there was a negative association between autistic features and functioning, quality of life and subjective treatment benefit; and a positive association with severity of disorder, severity of anxiety and depression, severity of positive and negative symptoms, suicidal ideation and behaviour, psychiatric comorbidity and number of psychotic episodes. Depression intensity mediated autistic features’ effect on suicidal thoughts. Those who were non-smokers and bullied by peers reported more autistic traits. Taken together, our results highlight the importance of autistic features in the psychosis spectrum. It is clear that there is a significant gap in clinical knowledge regarding the relationship between autism and psychosis and that further improvements in diagnostic tools and treatment options are needed. As our study is cross-sectional in design, speculation about causality is limited and further prospective research is needed.
- 1 October 2025
- Published by Springer Nature in BMC Psychiatry
- Vol. 25 (1) , 1-15
Open AccessClinical implications of autistic features in the psychosis spectrum: a cross-sectional study using path analysis
Despite the fact that there have been many studies on the connection between autism and psychosis, there are still many things that are unknown about the significance of this connection. Recent studies have highlighted the significant overlap between autistic traits and psychotic disorders, yet the clinical implications of these associations are not well understood. This study aims to address this knowledge gap by investigating the links between autistic features and various clinical, functional and behavioural outcomes in individuals with psychosis spectrum. The study included 125 patients who had at least one psychotic episode and who had used antipsychotic medication for most of the treatment period. The clinician conducted face-to-face interviews to evaluate all other clinical characteristics, while self-report scales were employed to evaluate autistic features and quality of life. Complex associations were understood using path analysis. Our study showed that there was a negative association between autistic features and functioning, quality of life and subjective treatment benefit; and a positive association with severity of disorder, severity of anxiety and depression, severity of positive and negative symptoms, suicidal ideation and behaviour, psychiatric comorbidity and number of psychotic episodes. Depression intensity mediated autistic features’ effect on suicidal thoughts. Those who were non-smokers and bullied by peers reported more autistic traits. Taken together, our results highlight the importance of autistic features in the psychosis spectrum. It is clear that there is a significant gap in clinical knowledge regarding the relationship between autism and psychosis and that further improvements in diagnostic tools and treatment options are needed. As our study is cross-sectional in design, speculation about causality is limited and further prospective research is needed.
- Open Access
- 10 September 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1639179
Hashimoto’s encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment
Introduction: Hashimoto’s encephalopathy (HE) is a rare neuro-inflammatory disorder that poses a significant diagnostic challenge, particularly when its clinical presentation is dominated by psychiatric symptomatology. This study aimed to delineate the constellation of clinical and paraclinical features that differentiate HE from primary psychiatric disorders among seropositive inpatients, thereby facilitating its early and accurate identification.Methods: In this retrospective, single-center study, the records of 484 consecutively admitted female psychiatric inpatients were reviewed. The final cohort comprised 40 patients with confirmed thyroid autoantibody seropositivity. Patients presenting with atypical features or suspected autoimmune etiologies were subjected to a comprehensive neurodiagnostic evaluation, including cerebrospinal fluid (CSF) analysis, electroencephalography (EEG), MRI, and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). The diagnosis of HE was established based on stringent criteria, including the exclusion of alternative etiologies and a definitive therapeutic response to corticosteroids.Results: Of the 40 seropositive patients, nine (22.5%) met the diagnostic criteria for definitive HE. The HE cohort exhibited a significantly later age of psychiatric symptom onset (42.9 vs. 30.1 years; p=0.011) and markedly greater functional impairment (GAF score: 31.7 vs. 51.6; pvs. 6.5% in non-HE; pvs. 32.3%; p=0.015). Corroborating neurodiagnostic evidence for HE included inflammatory CSF abnormalities (55.6% vs. 0%), diffuse EEG slowing (33.3% vs. 0%), and cortical hypometabolism on FDG-PET (85.7% vs. 0%). All patients with HE were refractory to standard psychiatric interventions but achieved prompt and substantial clinical remission following high-dose corticosteroid administration.Discussion: In conclusion, HE manifests as a distinct and severe neuropsychiatric syndrome in a subset of seropositive psychiatric inpatients. The emergence of a late-onset clinical picture characterized by a delirium-catatonia complex, particularly when refractory to conventional psychiatric treatment, warrants a high index of suspicion for HE. A multimodal diagnostic approach is essential for accurate identification, enabling the timely initiation of immunotherapy to ameliorate severe neuropsychiatric morbidity and prevent long-term disability
- 10 September 2025
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 16, 1639179
Open AccessHashimoto’s encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment
Introduction: Hashimoto’s encephalopathy (HE) is a rare neuro-inflammatory disorder that poses a significant diagnostic challenge, particularly when its clinical presentation is dominated by psychiatric symptomatology. This study aimed to delineate the constellation of clinical and paraclinical features that differentiate HE from primary psychiatric disorders among seropositive inpatients, thereby facilitating its early and accurate identification.Methods: In this retrospective, single-center study, the records of 484 consecutively admitted female psychiatric inpatients were reviewed. The final cohort comprised 40 patients with confirmed thyroid autoantibody seropositivity. Patients presenting with atypical features or suspected autoimmune etiologies were subjected to a comprehensive neurodiagnostic evaluation, including cerebrospinal fluid (CSF) analysis, electroencephalography (EEG), MRI, and 18F-fluorodeoxyglucose positron emission tomography (FDG-PET). The diagnosis of HE was established based on stringent criteria, including the exclusion of alternative etiologies and a definitive therapeutic response to corticosteroids.Results: Of the 40 seropositive patients, nine (22.5%) met the diagnostic criteria for definitive HE. The HE cohort exhibited a significantly later age of psychiatric symptom onset (42.9 vs. 30.1 years; p=0.011) and markedly greater functional impairment (GAF score: 31.7 vs. 51.6; pvs. 6.5% in non-HE; pvs. 32.3%; p=0.015). Corroborating neurodiagnostic evidence for HE included inflammatory CSF abnormalities (55.6% vs. 0%), diffuse EEG slowing (33.3% vs. 0%), and cortical hypometabolism on FDG-PET (85.7% vs. 0%). All patients with HE were refractory to standard psychiatric interventions but achieved prompt and substantial clinical remission following high-dose corticosteroid administration.Discussion: In conclusion, HE manifests as a distinct and severe neuropsychiatric syndrome in a subset of seropositive psychiatric inpatients. The emergence of a late-onset clinical picture characterized by a delirium-catatonia complex, particularly when refractory to conventional psychiatric treatment, warrants a high index of suspicion for HE. A multimodal diagnostic approach is essential for accurate identification, enabling the timely initiation of immunotherapy to ameliorate severe neuropsychiatric morbidity and prevent long-term disability
- Open Access
- 15 August 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (5) , e182
Retrospective chart review of cases of steroid-responsive catatonia: exploring a potential autoimmune aetiology
Background: Catatonia, a neuropsychiatric syndrome, can be associated with inflammatory conditions of the central nervous system. Aims: To explore steroid-responsive catatonia with possible autoimmune origins. Method: A retrospective investigation was conducted of clinical and paraclinical features, including imagining, serum, and cerebrospinal fluid findings in ten patients presenting with subacute onset catatonia and treated with steroid pulse therapy between January 2022 and January 2024. Results: A retrospective chart review identified ten patients (of a total of 56) with steroid-responsive subacute onset catatonia. Catatonia types varied. All patients were positive for delirium and psychotic symptoms. Imaging and cerebrospinal fluid results indicated non-specific signs of central nervous system inflammation. Intravenous 1 g methylprednisolone pulse therapy resulted in complete remission in all patients. Autoantibodies for limbic and paraneoplastic encephalitis were negative for all patients. None of the patients fulfilled the criteria for definite autoimmune encephalitis or autoantibody-negative probable autoimmune encephalitis. Conclusions: Diagnosis of autoimmune catatonia is challenging without autoantibody markers, but steroid responsiveness, combined with clinical and paraclinical features, may suggest an autoimmune mechanism.
- 15 August 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (5) , e182
Open AccessRetrospective chart review of cases of steroid-responsive catatonia: exploring a potential autoimmune aetiology
Background: Catatonia, a neuropsychiatric syndrome, can be associated with inflammatory conditions of the central nervous system. Aims: To explore steroid-responsive catatonia with possible autoimmune origins. Method: A retrospective investigation was conducted of clinical and paraclinical features, including imagining, serum, and cerebrospinal fluid findings in ten patients presenting with subacute onset catatonia and treated with steroid pulse therapy between January 2022 and January 2024. Results: A retrospective chart review identified ten patients (of a total of 56) with steroid-responsive subacute onset catatonia. Catatonia types varied. All patients were positive for delirium and psychotic symptoms. Imaging and cerebrospinal fluid results indicated non-specific signs of central nervous system inflammation. Intravenous 1 g methylprednisolone pulse therapy resulted in complete remission in all patients. Autoantibodies for limbic and paraneoplastic encephalitis were negative for all patients. None of the patients fulfilled the criteria for definite autoimmune encephalitis or autoantibody-negative probable autoimmune encephalitis. Conclusions: Diagnosis of autoimmune catatonia is challenging without autoantibody markers, but steroid responsiveness, combined with clinical and paraclinical features, may suggest an autoimmune mechanism.
- Open Access
- 28 August 2024
- Published by Wiley
PRE-TRANSPLANT DEPRESSION FOUND TO BE RELEATED TO DELAY OF NEUTROPHIL ENGRAFTMENT IN MULTIPLE MYELOMA PATIENTS WHO UNDERGO AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION
Objectives: Malignancy diagnosis and treatments, such as chemotherapy and transplantation processes, cause psychological stress for most of the patients. During the diagnosis and transplantation period, the possibility of an unfavorable outcome and the anticipated adverse effects of treatment are the major sources of stress and negatively affect the psychological status of the patients. It has been shown that physical and psychological status and stress prior to HSCT are closely related to treatment success. The present study was designed to investigate the possible negative effects of depression and anxiety on neutrophil and platelet engraftments in multiple myeloma patients who underwent autologous peripheral stem cell transplantation. Materials and Methods: Fifty-two patients completed the Hospital Anxiety and Depression Scale (HADS) before HSCT. Patients were divided into two groups according to the presence of depression or not. The neutrophil and platelet engraftment days of the patients with and without significant depressive symptoms were compared with Mann-Whitney U test. Results: The neutrophil engraftment was significantly delayed in patients with significant depressive symptoms (p=0.043). There was no difference in terms of the sociodemographic characteristics and treatment variables between the patients with or without significant depressive symptoms. Conclusion: The results of this study may support the presence of the effect of the prior psychological status on HSCT outcomes and also support the widely held belief that the central nervous system (CNS) is effective on the immune system.
- 28 August 2024
- Published by Wiley
Open AccessPRE-TRANSPLANT DEPRESSION FOUND TO BE RELEATED TO DELAY OF NEUTROPHIL ENGRAFTMENT IN MULTIPLE MYELOMA PATIENTS WHO UNDERGO AUTOLOGOUS PERIPHERAL STEM CELL TRANSPLANTATION
Objectives: Malignancy diagnosis and treatments, such as chemotherapy and transplantation processes, cause psychological stress for most of the patients. During the diagnosis and transplantation period, the possibility of an unfavorable outcome and the anticipated adverse effects of treatment are the major sources of stress and negatively affect the psychological status of the patients. It has been shown that physical and psychological status and stress prior to HSCT are closely related to treatment success. The present study was designed to investigate the possible negative effects of depression and anxiety on neutrophil and platelet engraftments in multiple myeloma patients who underwent autologous peripheral stem cell transplantation. Materials and Methods: Fifty-two patients completed the Hospital Anxiety and Depression Scale (HADS) before HSCT. Patients were divided into two groups according to the presence of depression or not. The neutrophil and platelet engraftment days of the patients with and without significant depressive symptoms were compared with Mann-Whitney U test. Results: The neutrophil engraftment was significantly delayed in patients with significant depressive symptoms (p=0.043). There was no difference in terms of the sociodemographic characteristics and treatment variables between the patients with or without significant depressive symptoms. Conclusion: The results of this study may support the presence of the effect of the prior psychological status on HSCT outcomes and also support the widely held belief that the central nervous system (CNS) is effective on the immune system.
- 29 July 2021
- Published by Galenos Yayinevi in Turkish Journal of Child and Adolescent Mental Health
- Vol. 28 (2) , 159-165
Relationship of Adolescents’ Just World Beliefs with Childhood Trauma and Attachment Styles
- 29 July 2021
- Published by Galenos Yayinevi in Turkish Journal of Child and Adolescent Mental Health
- Vol. 28 (2) , 159-165
Relationship of Adolescents’ Just World Beliefs with Childhood Trauma and Attachment Styles
- 1 January 2021
- Published by Bentham Science Publishers Ltd. in Adolescent Psychiatry
- Vol. 11 (4) , 240-259
Beier Sentence Completion Test Profiles of Adolescents and Emerging Adults With Internalizing and Externalizing Disorders
Background: Understanding adolescents' and emerging adults' psychiatric complaints and their relations with psychiatric disorders can be challenging. Beier Sentence Completion Test (BSCT), as a projective test, can be promising in this respect. However, relations between BSCT profiles and adolescent psychopathology are not well known. Aim: This study aimed to examine and compare BSCT profiles of adolescents and emerging adults with internalizing and externalizing disorders. As well as that, the relation of BSCT profiles with depression and anxiety scores was investigated. Objective: To achieve this aim, we retrospectively collected the hospital records of 300 adolescents and emerging adults (aged. 14-21) admitted to an Adolescent Psychiatry Outpatient Unit. Methods: The psychiatric diagnosis of the patients was classified as Internalizing (n = 100) and Externalizing (n = 100) disorder groups; the control group (n = 100) consisted of adolescents and young adults without any psychiatric diagnosis. BSCT, the Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) were administered on the first admission to all cases before psychiatric evaluation and treatment. BSCT total subfactor (positive, negative, neutral, and non-response) statement scores were compared between groups, and their correlations with BDI and BAI were investigated. Besides, multivariate logistic regression analyses were conducted for estimating any diagnostic group differences, as well as bivariate logistic regression analyses for estimating BDI and BAI cutoff scores with models that included BSCT total subfactor statement scores. Results: It was revealed that lower positive and non-response statements were crucial for distinguishing externalizing and internalizing disorders and that positive and negative statements were correlated with depression and anxiety scores.In the multivariate regression model, these correlations were predictive only for the relationship between internalizing disorders group and low positive statement scores, not higher negative statement scores that can be associated with lack of positive emotional processing in this group. Also, non response statement scores were found to be predictive for externalizing disorder groups. Similarly, BDI cut-off scores were predicted with low positive statement scores. Conclusion: BSCT profiles can be promising for understanding adolescents and emerging adults with internalizing and externalizing disorders. Lack of positive attributions to the self and other domains of life can be important for differentiating adolescent psychopathology.
- 1 January 2021
- Published by Bentham Science Publishers Ltd. in Adolescent Psychiatry
- Vol. 11 (4) , 240-259
Beier Sentence Completion Test Profiles of Adolescents and Emerging Adults With Internalizing and Externalizing Disorders
Background: Understanding adolescents' and emerging adults' psychiatric complaints and their relations with psychiatric disorders can be challenging. Beier Sentence Completion Test (BSCT), as a projective test, can be promising in this respect. However, relations between BSCT profiles and adolescent psychopathology are not well known. Aim: This study aimed to examine and compare BSCT profiles of adolescents and emerging adults with internalizing and externalizing disorders. As well as that, the relation of BSCT profiles with depression and anxiety scores was investigated. Objective: To achieve this aim, we retrospectively collected the hospital records of 300 adolescents and emerging adults (aged. 14-21) admitted to an Adolescent Psychiatry Outpatient Unit. Methods: The psychiatric diagnosis of the patients was classified as Internalizing (n = 100) and Externalizing (n = 100) disorder groups; the control group (n = 100) consisted of adolescents and young adults without any psychiatric diagnosis. BSCT, the Beck Depression Inventory (BDI), and Beck Anxiety Inventory (BAI) were administered on the first admission to all cases before psychiatric evaluation and treatment. BSCT total subfactor (positive, negative, neutral, and non-response) statement scores were compared between groups, and their correlations with BDI and BAI were investigated. Besides, multivariate logistic regression analyses were conducted for estimating any diagnostic group differences, as well as bivariate logistic regression analyses for estimating BDI and BAI cutoff scores with models that included BSCT total subfactor statement scores. Results: It was revealed that lower positive and non-response statements were crucial for distinguishing externalizing and internalizing disorders and that positive and negative statements were correlated with depression and anxiety scores.In the multivariate regression model, these correlations were predictive only for the relationship between internalizing disorders group and low positive statement scores, not higher negative statement scores that can be associated with lack of positive emotional processing in this group. Also, non response statement scores were found to be predictive for externalizing disorder groups. Similarly, BDI cut-off scores were predicted with low positive statement scores. Conclusion: BSCT profiles can be promising for understanding adolescents and emerging adults with internalizing and externalizing disorders. Lack of positive attributions to the self and other domains of life can be important for differentiating adolescent psychopathology.
- Open Access
- 1 January 2018
- Published by Turkish Association of Nervous and Mental Health in Turkish Journal of Psychiatry
- Vol. 29 (3) , 162-170
Psychosocial Functioning in Euthymic Patients with Bipolar Disorder Type - II and Associated Clinical and Cognitive Factors
The aim of this study was to investigate psychosocial functioning of euthymic Bipolar Disorder Type-II (BD-II) patients and the association between psychosocial functioning with cognitive functions and subclinical symptoms. The hypothesis was BD-II patients would have low level of psychosocial functioning comparing to healthy subjects and psychosocial functioning would be associated independently with cognitive dysfunction and subclinical symptoms. Thirthy-three subjects who met criteria for BD-II according to Structured Clinical Interview for DSM-IV and thirty-five healthy subjects were included. Clinical symptoms were assessed by Hamilton Depression Rating Scale (HDRS), Young Mania Rating Scale (YMRS); Hamilton Anxiety Rating Scale (HARS); psychosocial functioning was assessed by Functioning Assessment Short Test (FAST). Neurocognitive assessment battery was consisted of WAIS-R general information subtest; Wisconsin Card Sorting Test (WCST) perseverative errors, nonperseverative errors and category completed subtests; Trail Making Test-B (TMT-B); Stroop TBAG form; Trail Making Test-A(TMT-A) Auditory Consonant Trigrams (ACT) ACT; Wechsler Memory Scale Revised (WMS-R). Clinical symptoms assessed by HDRS, HARS scores; psychosocial functioning scores assessed by FAST; neurocognitive functions assessed by WCST category completed and, TMT-B, Stroop test, TMT-A, ACT, and WMS-R scores were significantly different between the two groups. FAST scores were associated with ACT scores in BB-II group. BB-II patients had cognitive dysfunctions and low level of psychosocial functioning even in their euthymic states. Working memory dysfunction was independently associated with psychosocial functioning of euthymic BB-II patients.
- 1 January 2018
- Published by Turkish Association of Nervous and Mental Health in Turkish Journal of Psychiatry
- Vol. 29 (3) , 162-170
Open AccessPsychosocial Functioning in Euthymic Patients with Bipolar Disorder Type - II and Associated Clinical and Cognitive Factors
The aim of this study was to investigate psychosocial functioning of euthymic Bipolar Disorder Type-II (BD-II) patients and the association between psychosocial functioning with cognitive functions and subclinical symptoms. The hypothesis was BD-II patients would have low level of psychosocial functioning comparing to healthy subjects and psychosocial functioning would be associated independently with cognitive dysfunction and subclinical symptoms. Thirthy-three subjects who met criteria for BD-II according to Structured Clinical Interview for DSM-IV and thirty-five healthy subjects were included. Clinical symptoms were assessed by Hamilton Depression Rating Scale (HDRS), Young Mania Rating Scale (YMRS); Hamilton Anxiety Rating Scale (HARS); psychosocial functioning was assessed by Functioning Assessment Short Test (FAST). Neurocognitive assessment battery was consisted of WAIS-R general information subtest; Wisconsin Card Sorting Test (WCST) perseverative errors, nonperseverative errors and category completed subtests; Trail Making Test-B (TMT-B); Stroop TBAG form; Trail Making Test-A(TMT-A) Auditory Consonant Trigrams (ACT) ACT; Wechsler Memory Scale Revised (WMS-R). Clinical symptoms assessed by HDRS, HARS scores; psychosocial functioning scores assessed by FAST; neurocognitive functions assessed by WCST category completed and, TMT-B, Stroop test, TMT-A, ACT, and WMS-R scores were significantly different between the two groups. FAST scores were associated with ACT scores in BB-II group. BB-II patients had cognitive dysfunctions and low level of psychosocial functioning even in their euthymic states. Working memory dysfunction was independently associated with psychosocial functioning of euthymic BB-II patients.